Clinical Trials Directory

Trials / Completed

CompletedNCT05923593

Tolerance and Safety of an Oral Nutritional Supplement (Adolescent Cohort)

Tolerance and Safety of an Oral Nutritional Supplement Containing Monoacylglycerol Oil (MAG Oil) as the Main Lipid Source in Healthy Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
12 Years – 17 Years
Healthy volunteers
Accepted

Summary

This is an open label, non-randomized, interventional, single arm study.

Detailed description

The primary objective is to assess whether the MAG oil-containing study formula is well tolerated and safe when used as an ONS in healthy adolescents. Hypothesis: The study product will be safe and well tolerated in healthy adolescents (as previously observed in adults). Secondary objectives: 1. Describe the frequency and characteristics of possible gastrointestinal intolerance symptoms 2. Describe stool characteristics specifically stool frequency and consistency 3. Describe changes in anthropometric parameters, particularly weight and body mass index (BMI) 4. Describe changes in blood parameters of lipid metabolism 5. Describe changes in hematological and serum biochemistry parameters 6. Describe daily ONS intake and overall compliance

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMAG oil oral nutritional supplement (ONS)The study product is suitable for use as an oral nutritional supplement (ONS).The study product contains MAG oil.

Timeline

Start date
2023-03-20
Primary completion
2023-06-15
Completion
2023-08-30
First posted
2023-06-28
Last updated
2023-10-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05923593. Inclusion in this directory is not an endorsement.